Region: North America
Category: Pharmaceuticals

North America Pharmaceuticals

(4,457 reports matching your criteria)
  • Intracranial Aneurysm

    ... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More

  • Books

    ... 2.9% over the analysis period 2024-2030. Mystery Books, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$35.4 Billion by the end of the analysis period. Growth ... Read More

  • Healthcare Distribution

    ... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis ... Read More

  • Artificial Insemination

    ... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More

  • Box Office

    ... CAGR of 15.5% over the analysis period 2024-2030. Action / Adventure Genre, one of the segments analyzed in the report, is expected to record a 17.7% CAGR and reach US$49.0 Billion by the end of ... Read More

  • Counter Cyber Terrorism

    ... at a CAGR of 2.8% over the analysis period 2024-2030. Firewall, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$19.1 Billion by the end of the ... Read More

  • Swine Health

    ... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More

  • Flea and Tick Products

    ... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Chewable Products, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$7.3 Billion by the ... Read More

  • Insulin Pens

    ... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More

  • Gensets

    ... 5.6% over the analysis period 2024-2030. Diesel Gensets, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.1 Billion by the end of the analysis period. Growth ... Read More

  • Hair Transplant Services

    ... at a CAGR of 14.3% over the analysis period 2024-2030. Follicular Unit Extraction Procedure, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$14.3 Billion by the ... Read More

  • Personal Finance Software

    ... at a CAGR of 5.0% over the analysis period 2024-2030. Web-based Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$941.0 Million by the end of ... Read More

  • Online Home Rental Services

    ... 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Flats Rental Services, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$40.3 Billion by ... Read More

  • Home Care Services

    ... at a CAGR of 7.3% over the analysis period 2024-2030. Maid Services, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.7 Billion by the end of ... Read More

  • Hybrid and Electric Vehicle Fuses

    ... Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2024-2030. Hybrid Electric Vehicles (HEVs) Application, one of the segments analyzed in the report, is expected to record a 25.2% CAGR and ... Read More

  • Spring and Wire Products

    ... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$47.0 Billion by the end ... Read More

  • Hospitals and Outpatient Care Centers

    ... Trillion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.1 Trillion While China is Forecast to Grow at 7.6% CAGR The Hospitals and Outpatient ... Read More

  • Vial Adaptors for Reconstitution Drug

    ... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More

  • Vancomycin

    ... 4.9% over the analysis period 2024-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. ... Read More

  • Pediatric Interventional Cardiology Devices

    ... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More

  • Therapeutic Respiratory Devices

    ... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More

  • Probiotics Dietary Supplements

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by the end of ... Read More

  • Generic Drugs

    ... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More

  • Soldier Systems

    ... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the ... Read More

  • Herpes Marker Testing

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More

Cookie Settings